The recombinant cytokine NGR-TNF, carrying the CNGRC tumor homing peptide [1], has shown a higher anti-tumor activity than the corresponding wild type cytokine in animal models [2], thus allowing its use at low, not toxic concentrations. This evidence concerns the gene TNF and neoplasm.